sipavibart
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 16, 2025 (NCT07021794)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Mechanism of action
- SARS-CoV-2INHIBITOR
SARS-CoV-2 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5315011 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07021794 | Phase 2 | Jun 16, 2025 | Florida Department of Health, Nova Southeastern University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Florida Department of Health | Government | 1 | 0 | 1 | 2025 |
| Nova Southeastern University | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1